Law: Clayton Antitrust Act 1914 (USA)

Firms line up for largest pharma merger since 2020

Pfizer has tapped Arnold & Porter and Wachtell Lipton Rosen & Katz to steer its $43 billion acquisition of Seagen, which is advised by Sullivan & Cromwell.

14 March 2023

DOJ doubles down on Section 8 enforcement

Five company directors have resigned from their leadership roles and one firm gave up its right to appoint directors at a rival after the Department of Justice raised concerns over suspected violations of Section 8 of the Clayton Act.

10 March 2023

Mekki: bringing more cases will improve enforcement success

The judiciary has failed to understand some competition concerns because the agencies have not brought enough cases in recent decades, the number-two-in-command at the Department of Justice’s antitrust division has said.

03 March 2023

States’ third generic pharma collusion case survives

A coalition of 46 state attorneys general have adequately alleged that major drugmakers conspired to fix prices for generic skin treatments, but a Philadelphia federal court will not let them seek disgorgement on behalf of their citizens.

01 March 2023

Private merger challenge can seek divestiture, court finds

Retail investors may pursue the breakup of Charles Schwab/TD Ameritrade, a Texas federal judge has ruled in rejecting the brokerage firm's motion to dismiss.

01 March 2023

Google: class action fails to allege illegal Maps tie

A group of companies accusing Google of cornering off the market for digital mapping products have failed to correct the errors that saw their original complaint rejected, the defendant has argued.

22 February 2023

Investors using interlocking directorate to derail cannabis deal, rival says

An investor in cannabis firm RIV Capital has accused a co-investor of attempting to derail an acquisition and obtain sensitive information to give its competing marijuana company TerrAscend a leg-up in the industry.

08 February 2023

Meta/Within ruling clarifies potential competition burdens, experts say

The Federal Trade Commission’s failure to block Meta Platforms/Within Unlimited underlines the legal challenges of proving harm to potential competition, but possibly moves the needle in its favour for future cases, experts have said.

07 February 2023

Meta not incentivised to make own fitness app, court finds

The Federal Trade Commission failed to show that Meta Platforms was likely to enter the virtual reality fitness realm absent its acquisition of Within Unlimited, a California federal judge has ruled.

06 February 2023

Microsoft: Gamers cannot block Activision merger

A group of video gamers cannot seek a preliminary injunction against Microsoft’s $68.4 billion proposed acquisition of developer Activision Blizzard because the merging parties still have to finalise the transaction, the companies have argued.

02 February 2023

Unlock unlimited access to all Global Competition Review content